Ingersoll Rand INC

Market Movers (8-K)

See all →
NYSE
Ingersoll Rand announced robust second quarter 2026 financial results, driven by strong organic growth and effective execution.
NYSE
Ingersoll Rand stockholders approved the 2026 Omnibus Incentive Plan and re-elected the Board of Directors at the 2026 Annual Meeting.
NYSE
Ingersoll Rand announced first quarter 2026 financial results, demonstrating solid performance with growth in orders and revenue, while maintaining full-year guidance.
NYSE
Ingersoll Rand Inc. announced the appointment of former Tesla President Jerome Guillen to its Board of Directors, effective January 1, 2026, expanding the board to ten members.
NYSE
Ingersoll Rand Inc. announced strong financial results for the third quarter of 2025, driven by robust orders and revenue growth across both segments.
NYSE
Ingersoll Rand Inc. announced record second quarter 2025 orders, revenues, and adjusted EBITDA, while raising its full-year guidance for revenue, adjusted EBITDA, and adjusted EPS, despite reporting a net loss primarily due to non-cash impairments.
Better than expected

Quarterly Earnings (10-Q)

See all →
NYSE
Ingersoll Rand Inc. announced its financial results for the second quarter ended June 30, 2026, showcasing significant revenue growth and improved net income compared to the prior year.
NYSE
Ingersoll Rand reported a 5.1% revenue increase in Q3 2025, driven by acquisitions and pricing, but significant goodwill and equity investment impairments led to a nearly 50% drop in nine-month net income.
Worse than expected
NYSE
Ingersoll Rand Inc. reported a net loss of $115.3 million for the second quarter of 2025, primarily driven by $229.7 million in goodwill impairment, $36.1 million in other intangible asset impairment, and a $120.9 million impairment of an equity method investment, despite a 4.6% increase in revenues to $1.89 billion.
Worse than expected
Capital raise
NYSE
Ingersoll Rand's Q1 2025 results show revenue growth driven by acquisitions but tempered by organic volume declines and foreign currency headwinds.
Worse than expected
NYSE
Ingersoll Rand's Q3 2024 results show revenue growth driven by acquisitions and pricing, with increased profitability despite some volume declines.
Better than expected
Capital raise
NYSE
Ingersoll Rand's Q2 2024 results show revenue growth driven by acquisitions and pricing, despite some volume declines and currency headwinds.
Better than expected
Capital raise

Annual Reports (10-K)

NYSE
Ingersoll Rand's 2024 10-K filing reveals a 5.2% increase in revenue and a 10.0% increase in gross profit, driven by strategic acquisitions and pricing actions, despite challenges from lower organic volumes and currency headwinds.
NYSE
Ingersoll Rand's 10-K filing details the company's securities, financial performance, and risk factors for the fiscal year ended December 31, 2023.
Better than expected

Insider Trading (Form 4)

See all →
NYSE
Matthew J Emmerich, See Remarks of Ingersoll Rand Inc., reported multiple transactions in common stock on August 17, 2026.
NYSE
Michael A Weatherred, See Remarks of Ingersoll Rand Inc., reported multiple transactions in common stock on August 6, 2026.
NYSE
Andrew R Schiesl, See Remarks of Ingersoll Rand Inc., reported multiple transactions in common stock on August 6, 2026.
NYSE
Aurobind Satpathy, a Director of Ingersoll Rand Inc., reported multiple transactions in common stock on August 6, 2026.
NYSE
Michelle Swanenburg, a Director of Ingersoll Rand Inc., reported multiple transactions in common stock on August 6, 2026.
NYSE
Aurobind Satpathy, a Director of Ingersoll Rand Inc., purchased 11,538 shares of common stock on August 3, 2026 for $86.68 per share.

Proxy Statements (Def-14A)

NYSE
Ingersoll Rand Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 11, 2026.
NYSE
Ingersoll Rand Inc. has filed a definitive proxy statement with the SEC.
NYSE
Ingersoll Rand's proxy statement details the agenda for the 2025 Annual Meeting of Stockholders, executive compensation, and corporate governance practices.
NYSE
Ingersoll Rand Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NYSE
Ingersoll Rand's 2024 proxy statement outlines proposals for the annual stockholder meeting, including director elections, auditor ratification, and executive compensation approval.

Schedule 13G - Passive Investments

See all →
NYSE
Capital Research Global Investors has reported a beneficial ownership of 6.4% in Ingersoll-Rand, Inc., holding 25,217,116 shares.
NYSE
FMR LLC and Abigail P. Johnson have updated their beneficial ownership filing for Ingersoll Rand Inc., reporting a 3.4% stake in the company's common stock as of June 30, 2026.
NYSE
T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 4.5% of Ingersoll Rand Inc.'s common stock as of March 31, 2026.
NYSE
Capital Research Global Investors has reported a significant stake in Ingersoll-Rand, Inc., now holding 7.5% of the company's common stock.
NYSE
FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 5.3% of Ingersoll Rand Inc.'s common stock as of March 31, 2026.
NYSE
Vanguard Capital Management has reported beneficial ownership of 28,008,776 shares, representing 7.15% of the outstanding common stock of Ingersoll Rand Inc.